The College of Science and Mathematics’ Advisory Board provides guidance, support and advocacy for the College’s pedagogical, research and outreach programs. These individuals bridge the College and the external community with their professional insights into current educational, economic, national and international needs. They assist the College in identifying emerging research and educational programs, sources for financial and professional student support and collaborations for programs and research.
Dr. John Anthes, PhD
Director, Integrative Science
Bristol-Myers Squibb Company
Prior to being a Director of the Thomas O. Daniel Research Incubator and Collaboration Center at Bristol-Myers Squibb, acquired from Celgene, Dr. John Anthes was a Director of Biomedical Licensing at Rutgers University. In this role, he was responsible for evaluation and commercialization of the intellectual property of key Rutgers faculty. This included patenting, licensing, research contracts and NewCo activities. In addition, he was engaged in corporate outreach and liaison with University technology transfer offices throughout the country. Before Rutgers, Dr. Anthes was a Director of External Scientific Affairs at Merck, involved with coordinating and driving decisions of due diligence teams regarding in-licensing opportunities. Prior to the acquisition by Merck, Dr. Anthes was a Research Fellow at Schering-Plough, involved with the preclinical pharmacological characterization of several clinical candidates including commercial products Claritin, Clarinex, Nasonex and Dulera.
Dr. John F. Bonamo, MD
Executive Vice President and Chief Medical and Quality Officer
Dr. John F. Bonamo, Executive Vice President and Chief Medical and Quality Officer for RWJBarnabas Health, is a physician executive with a distinguished clinical background in obstetrics and gynecology and hospital leadership. Dr. Bonamo earned his M.D. degree from the University of Medicine and Dentistry of New Jersey. He completed an internship and residency in Obstetrics and Gynecology at Saint Barnabas Medical Center in 1981, and immediately joined the Medical Staff at Saint Barnabas. Dr. Bonamo is board certified by the American Board of Obstetrics and Gynecology. From 1981 through 1999, he had a busy private practice in West Orange, New Jersey and was a highly respected obstetrician and gynecologist. In January 2000, he left private practice to assume the administrative position of Senior Vice President for Medical Affairs at Saint Barnabas Medical Center. He served in that position until April 2001, at which time he was appointed President and Chief Executive Officer. Building on his experience as a physician and as an administrator, Dr. Bonamo enrolled in the Harvard School of Public Health at Harvard University, and in 2003 earned a degree of Master of Science in Health Care Management. He now serves as an adjunct lecturer in the Health Policy and Management Department in the School of Public Health, as well as a visiting Professor at the University of Beijing Masters’ Program for hospital management. Dr. Bonamo is a Fellow of the American College of Healthcare Executives, of the American Board of Obstetricians and Gynecologists, and is a member of the New Jersey Obstetrical and Gynecological Society.
Dr. Barbara Brummer, PhD ’68
Dr. Barbara Brummer is the State Director at The Nature Conservancy of New Jersey where she is the key leader of the Conservancy’s program in New Jersey. A longstanding member of the Conservancy, Dr. Brummer was hired as State Director in January 2004. Prior to joining the Conservancy, she had retired from a successful career in the private sector, spending the last twelve years as an executive with Johnson & Johnson. Among her positions at J&J, she served as President of J&J Canada Inc. and Worldwide Vice President of the Women’s Health and Wellness Franchise. Throughout her career Barbara has maintained a passionate interest in conservation. For many years, she taught a course in field biology at Montclair State University and has spent many hours seeking out natural areas and studying the flora of New Jersey. In addition to her longstanding membership in The Nature Conservancy, Barbara has also been active in other local conservation organizations, serving on the boards of the New Jersey Audubon Society, the Pocono Environmental Education Center and the Palisades Nature Association. Soon after joining The Nature Conservancy, she was appointed by the Commissioner of the New Jersey Department of Environmental Protection to the Endangered and Non-Game Species Advisory Committee. Barbara is active with her alma mater, serving as the Chair of this Board as well as the Campaign Cabinet at Montclair State University. She has a B.A. in Biology from Montclair State University and a Ph.D. in Biological Sciences from New York University.
Mr. Ronald M. Califre ’72 ’08 HON
Senior Vice President of R&D and Head of US Operations, Retired
Novartis Pharmaceuticals Corporation
Vice Chair, CSAM Advisory Board
Mr. Ron Califre started his career with the U.S. Food and Drug Administration, where he worked for ten years in positions of increasing responsibility. He then joined Ciba-Geigy in Regulatory Affairs, eventually heading that function before being promoted to Sr. V.P., Medicine and Clinical Development, U.S. In that capacity, he was responsible for all aspects of drug development and medical and regulatory affairs, as well as heading the global neuroscience review board. At the time of the merger with Sandoz to form Novartis, Ron was appointed Sr. V.P., Drug Development. He later assumed responsibility for the discovery research functions, becoming Sr. V. P. of Research and Development, overseeing the activities of appx. 2400 people in drug discovery, pre-clinical research, early development, technical development, clinical development, drug safety, and regulatory affairs in the U.S. He was a member of the Research Management Board and the Development Leadership Team and served on the Boards of several companies and non-profit organizations. Following his retirement from Novartis, he has remained active on the advisory boards of several universities as well as engaging in independent consulting. He is a graduate of Montclair State College (B.A. ’72) and has done graduate work in pharmacy, pharmacology and food and drug law.
Mr. Mario M. Casabona
Founder and Managing Partner
Casabona Ventures, LLC
Mr. Mario M. Casabona is an entrepreneur and active angel investor. In 2012, he founded TechLaunch, committed to identifying and nurturing early stage tech ventures by mentoring, coaching, and providing access to resources and capital. To date, TechLaunch has supported over 100 tech companies and mentored over 200 aspiring entrepreneurs. In 2006, he founded Casabona Ventures, investing in over 30 seed and early stage companies. In 1982, he founded Electro-Radiation Inc., which was acquired by Honeywell International in 2004. He received the Small Business Administration National Tibbett’s Award for his contributions in technology, and was listed as one of the top five most influential persons in New Jersey technology by The Star-Ledger. He was twice recognized by the New Jersey Technology Council, (now TechUnited:NJ) first as the recipient of their Financier of the Year Award and subsequently their Legend of Technology Award. He is Chairman Emeritus of Jumpstart NJ Angel Network and Chairman Emeritus of the R&D Council of New Jersey. He also enjoys serving on the Boards of various for-profit and non-for-profit organizations. Mr. Casabona is an electrical engineer and holds twelve national and international patents in the field of satellite-based navigation and communications.
Dr. Francis M.C. Cuss, MB, BChir
Dr. Francis M. Cuss is a physician-scientist, with a background in general and academic medicine. He has developed a broad experience in pharmaceutical research, in clinical development and in executive management within globally-operating biopharma companies. Dr. Cuss’ career spans more than 30 years in the pharmaceutical industry, specifically with BMS, Schering-Plough and Glaxo. Francis retired from Bristol-Myers Squibb in July 2017 having served as Executive Vice President and Chief Scientific Officer since July 2013 and as a member of BMS’s Senior Management Team since 2010. He joined Bristol-Myers Squibb in 2003. Francis spent nearly a decade leading a very productive discovery organization which produced an innovative pipeline from both in-house and external programs. Their work helped numerous patients prevail against serious disease and laid the foundation for the generation of significant company growth and value. In addition to his participation on this Board and the University’s Board of Trustees, he is a member of the board of directors of Novo Holdings A/S, Denmark, Rubius Therapeutics, Cambridge MA. Prior to joining the pharmaceutical industry, Francis was a practicing physician with a specialization in pulmonary medicine in the UK. He received his education and medical training in the United Kingdom. He holds medical degrees from Cambridge University, U.K. and is a fellow of the Royal College of Physicians and the Faculty of Pharmaceutical Medicine. He has published numerous articles and book chapters on topics of medical interest.
Mr. Terence J. Gunning, MBA ’79
Lone Oak Business Solution
Mr. Terence J. Gunning has 30 years of management experience in the healthcare industry including diagnostic testing and services, medical devices and consumer healthcare products. He was Chief Executive Officer of Lone Oak Business Solutions, a life sciences consulting firm. Prior to Lone Oak Business Solutions, Terry was CEO of Cadent, a worldwide medical service and device start-up headquartered in Carlstadt, New Jersey. Terry’s tenure as Cadent’s CEO brought a tripling of revenue and significant improvement in operating profit and cash flow concurrent with several successful capital funding campaigns which paved the way for a successful strategic exit. As President of Datascope’s Cardiac Assist Division (CA) Terry brought significant sales increases, the launch of three new products, CA’s first successful acquisition and re-establishment of CA as the worldwide leader in counter-pulsation therapy. As Vice President and Head of the Corporate Anatomic Pathology Division, and as Vice President, Marketing, for Quest Diagnostics, he led several growth initiatives resulting in significant top- and bottom-line improvements. His resume includes marketing-related senior management positions with Johnson & Johnson Consumer Products and Bristol-Myers Squibb. Terry earned his MBA – Finance and Accounting at Columbia University and BS in Chemistry at Montclair State University.
Ms. Rachael N. Jones, MPA ’99
Senior Vice President of Performance Analytics & Quality
Ms. Rachael Jones is the Senior Vice President, Performance Analytics & Quality at Cotiviti, a leading solutions and analytics company that leverages unparalleled clinical and financial datasets to deliver deep insight into the performance of the healthcare system. These insights uncover new opportunities for healthcare organizations to collaborate to improve their financial performance, reduce inefficiency, and improve healthcare quality. In her role, she has accountability for business unit strategy, product vision, team, and market impact for one of the company’s high-growth verticals, Performance Analytics & Quality. This vertical allows health plans to move from simply reporting quality measures to driving the purchase, delivery, and utilization of higher value healthcare. Prior to her current role, she was Vice President, Growth & Account Management for Anthem’s Diversified Business Group (DBG) division which is focused on delivering whole person care to radically transform the healthcare industry. She led a team that leveraged the commercial experience of Anthem, the nation’s largest Blue health plan, bringing strategic solutions to health plans across the country. Focusing on a range of health plan needs, these solutions offer critical insights on how to personalize and integrate care for those with complex and chronic conditions. Backed by nearly two decades of health care and technology experience, Rachael is well recognized for her expertise in solution sales, delivery and product management, and as an innovator in cost-of-care and provider reimbursement strategies. Prior to her current role, she had financial oversight of payment innovation programs, as well as analytics product development that drove the shift from volume to value-based payment models. Within the healthcare industry, Rachael has also held leadership roles at Healthfirst, LLC, where she served as Assistant Vice President of Financial Analysis, overseeing regulatory reporting, shared risk/ACO performance analysis and as a leader of the organization’s Data Governance/MDM programs. In addition, she was Director of Product Management for the TriZetto Group, where she helmed a $200 million expansion and new product and service launch for value-based care analytics. Rachael earned her BS from Montclair State University and a MPA from New York University. She is a member of PHAM, the Professional Academy for Healthcare Management.
Mr. Mark Koehne
Senior Vice President and Actuary, Retired
Mutual of America Life Insurance Company
Recently retired in the Fall of 2020, Mr. Mark Koehne was the Senior Vice President and Actuary for Mutual of America’s Actuarial Consulting Services Department. Since 2003, he has been responsible for leading the 23 member Actuarial Consulting Services Department. They provide actuarial valuations and other services required for the ongoing funding and administration of defined benefit plans sponsored by over 125 clients. The department also provide design and compliance services to defined contribution type plans. Mr. Koehne has over 40 years of experience in the valuation and design of defined benefit and defined contribution plans and has spent over 30 years working specifically with plans of not-for-profit employers, including multiple employer plans. Most recently, he has spearheaded the company’s successful re-entry into the pension risk transfer space. Mr. Koehne began his career with Mutual of America in 1975. Prior to rejoining the firm in 1996, Mr. Koehne was employed as a Vice President with Alexander & Alexander for 10 years during which time he worked with a number of Fortune 500 clients and other nationally recognized firms. He graduated from the College of Insurance with a Bachelor of Science degree in Actuarial Sciences. Mr. Koehne is an Enrolled Actuary and a member of the American Academy of Actuaries. He is a member of the Pension Board for the Archdiocese of Newark, where he also chairs the Investment Committee, the Pension Board of the Diocese of Metuchen, and the New York State Actuarial Advisory Committee.
Mr. Michael Mancuso, FCAS, MAAA, ’09
AEGIS Insurance Services, Inc.
Mr. Michael Mancuso is a Fellow of the Casualty Actuarial Society and a Member of the American Academy of Actuaries. He has a wide array of actuarial experience, having started his career in the pensions field where he performed valuations of defined benefits and defined contributions plans. He transitioned into the specialty insurance field where he was responsible for the pricing and reserving of travel (re)insurance, and then ultimately found his niche within the property and casualty insurance industry. In his current role at AEGIS, a leading mutual insurance company for the energy industry, Michael manages the portfolio of reserve liabilities, leads the actuarial financial reporting function, and serves as the actuarial director for enterprise integration of analytic processes. Since graduating with a Bachelor of Science in Applied Mathematics from Montclair State University, Michael has discovered a passion for volunteerism and has been actively involved in supporting his alma mater as a frequent panelist for the CSAM Professional Development Series for Students. Additionally, Michael volunteers on a number of committees within the Casualty Actuarial Society (CAS), including serving as the University Liaison to Montclair State University to support the academic advisement of actuarial students. He is also a member of the CAS Examination Committee, and is a mentor for the CAS Student Central Summer Program. He continues to identify ways to support and foster students and recent graduates who are pursuing paths in actuarial science.
Mr. Anthony J. Matarazzo, MS ’94
Director, Environmental Health and Safety Audit
Mr. Anthony Matarazzo is the Director, Environmental Health and Safety Audit for American Water in Camden NJ Since 2019. Previously, Anthony served 18 years as Senior Director, Water Quality and Environmental Management at New Jersey American Water, and has been a company leader since 2003. He has actively collaborated with various faculty at Montclair State, including the Passaic River Institute, and is passionate about providing career-building jobs opportunities for the next generation of science students. Anthony has had several of CSAM’s own Green Team students on his Water Quality staff. Anthony is a proud alumnus of Montclair State University where he earned his MS in Environmental Management in 1994. Prior to that he earned a BS degree at Rutgers, majoring in Biology and Chemistry. He enjoys travel and is an avid fisherman.
Ms. Twinkle Morgan, MBA
Cooperman College Scholars
Ms. Twinkle Morgan is the founding Executive Director of the Cooperman College Scholars, a scholarship program targeting academically talented students who are traditionally underrepresented in higher education. Morgan has a passion for the issues surrounding college access for underserved communities. This passion led her to develop, design and implement The Fellowship Initiative (TFI), a JPMorgan Chase & Co. program to expand academic and professional opportunities for young men of color. As founding Executive Director of TFI, she established TFI’s New York operations in 2010 before its replication across three other US regions in 2014. Prior to this role, Morgan served as the founding Director of Development with Uncommon Schools, a nationally recognized charter management organization. They start and manage outstanding charter public schools that close the achievement gap and prepare underrepresented students to graduate from college. Morgan served as Director of Development for just under five years, raising more than $27 million in private and public grants. From 2000 to 2005, she was a Vice President Relationship Manager with JPMorgan Private Bank. Before working on Wall Street, Morgan worked with Accenture for three years as a Strategy Consultant. Her work in the early years of her career included developing pre-college programs for the National Association of Black Engineers (NSBE) and college support services at Georgia Tech’s Office of Minority Educational Development (OMED). A native of Louisiana, she completed a B.S. in Mathematics from Spelman College in 1995 and a B.S. in Industrial Engineering from the Georgia Institute of Technology in 1996 as a National Aeronautics and Space Administration (NASA) Scholar, supporting Johnson Space Center’s flight simulation team. Morgan earned an MBA from the Wharton Business School in 2001.
Dr. Marc Morresi, MD ’99
Summit Medical Group
Dr. Marc Morresi is an Internist at Summit Medical Group. He brings a wealth of experiences to a practice in Bloomfield, the town where he grew up, along with a lifelong ambition to be caring, compassionate physician. Prior to joining SMG in 2016, Marc developed and ran Morresi Medical Associates from 2011. He attended Seton Hall Prep for high school and on to NJIT for college. However, following a first-hand experience during a student tour at MSU, he knew that was the place for him, transferred and ultimately graduated from Montclair with a degree in Biology in 1999. Marc earned his M.D. from Saba University School of Medicine in Netherlands-Antilles in 2005. He graduated from his residency in Internal Medicine at UMDNJ-NJ in 2010 after a year as Chief Resident at Hackensack University Medical Center in 2009. Marc has been a physician at Hackensack University Medical Center and Hackensack Meridian Mountainside Hospital. Marc has served on several committees at Mountainside Hospital including the Credentialing Committee and as a current member of the Board of Trustees for the last five years.
Ms. Linda J. Obenauer-Kutner, MA ’80 ’83
Senior Principal Scientist
Bristol-Myers Squibb Company
Ms. Linda J. Obenauer-Kutner is a Scientist and a cancer survivor, Linda is a passionate supporter of science advocacy and giving back to the community. Linda has been a Pharmaceutical industry professional for over 25 years. As an analytical CMC lead at Bristol-Myers Squibb, she has been a significant contributor to the initial filing of Opdivo, an Immuno-Oncology treatment for different cancer types. She continues contributing towards formulation development in a senior research scientist role in R&D. She joined BMS in 2006 from Schering-Plough Research Institute (currently Merck). Linda supports outreach efforts through her association with organizations like Association for Women in Science (AWIS) and is a core team member of the BMS Adoption Community Network (ACN). As the treasurer for AWIS New Jersey she volunteers her time supporting initiatives that promote policies to increase representation and leadership positions for women. AWIS is a multi-disciplinary organization for women in science, technology, engineering and mathematics (STEM) that fosters a positive public image of women in STEM. Linda holds a Bachelor of Science and Master of Arts degree in Biology from Montclair State University. She has numerous publications in peer-reviewed journals.
Ms. Meme Omogbai
CEO and Executive Director
College Art Association
Before joining the College Art Association, Ms. Meme Omogbai served as a member and past Board Chair of the New Jersey Historic Trust, one of four landmark entities dedicated to preservation of the state’s historic and cultural heritage. Named one of The Network Journal’s 25 Influential Black Women in Business, Meme has over 25 years of diversified experience in corporate, government, higher education and museum sectors. As the first American of African descent to chair the American Alliance of Museums, she led an initiative to rebrand the AAM as a global, inclusive alliance. She has been recognized in the United States Congressional Records. While COO and Trustee, she spearheaded a major transformation in operating performance at the Newark Museum and achieved four consecutive years of 4-star ratings for superior management. During her time as Deputy Assistant Chancellor of New Jersey’s Department of Higher Education, Meme was recognized with the New Jersey Meritorious Service Award for her work on college affordability initiatives for New Jersey families as well as Resolutions by the New Jersey State Legislature. She received her MBA in Finance & Management Consultancy from Rutgers University and holds a CPA. She has completed post-graduate work at Harvard University’s Executive Management Program and has earned the designation of Chartered Global Management Accountant (CGMA). She studied global museum executive leadership at the J. Paul Getty Trust Museum Leadership Institute where she also served on the faculty.
Dr. Sherrie Pietranico-Cole, PhD
Global Program Regulatory Director
Novartis Pharmaceuticals Corporation
Dr. Sherrie Pietranico-Cole received a B.A. in Chemistry from Douglass College, Rutgers University, and became the first African-American woman to graduate with a Ph.D. in Chemistry from the University of Pennsylvania in 1992. Dr. Pietranico-Cole has over 25 years of experience in pharmaceutical development with a record of accomplishment of successfully advancing medicines. Dr. Pietranico-Cole started her career in Discovery Chemistry at Hoffmann-La Roche where she rose to Sr. Research Leader, one of the highest positions on the science ladder at Roche. Dr. Pietranico-Cole was awarded the 2008 TWIN (Tribute to Women in Industry) award for her contributions to the industry. In 2011, Dr. Pietranico-Cole transitioned careers to Drug Regulatory Affairs at Roche and helped file a sNDA for Tamiflu, which achieved approval for the treatment of Influenza A and B in children under 1 year of age. In 2012, Dr. Pietranico-Cole joined Early Development Drug Regulatory Affairs at Novartis Pharmaceuticals Corporation when Roche closed the Nutley, NJ site. As a Global Program Regulatory Director, Dr. Pietranico-Cole provides global regulatory expertise to the research teams at the Novartis Institute of Biomedical Research (NIBR) to advance a diverse portfolio of transformative biologic and small molecule drugs. Dr. Pietranico-Cole is deeply committed to mentoring students and promoting diversity and inclusion. She was recently featured in the book African American Women Chemists in the Modern Era. Dr. Pietranico-Cole is looking forward to interacting with the diverse student population in the College of Science and Mathematics at Montclair State and creating more internship and mentoring opportunities.
Mr. Robert Pollock
Before joining E2PM, Mr. Robert Pollock was the Senior Director, Environmental Projects and Permitting at PSE&G. He brings biological and regulatory permitting, as well as, management experience acquired within the utility, private development and public sectors. He was responsible for the execution of the Manufactured Gas Plant (MGP) remediation program. Additionally, the preparation and implementation of high-level strategies necessary for obtaining regulatory approvals for approximately $2 billion in capital infrastructure projects annually. Previously as President and owner of Environmental Resource Consulting, LLC for seven years, he successfully developed a utility focus, identifying environmental regulatory requirements and delivering agency approvals for small to large business clients. Mr. Pollock is a graduate of Millersville University of Pennsylvania where he earned a B.S. in Environmental Science.
Ms. Sandra Powell-Elliott, MBA
Vice President of Life Sciences and Innovation
Hackensack Meridian Health
Ms. Sandra Powell-Elliott is the Vice President for Life Sciences and Innovation at Hackensack Meridian Health. Her role is to foster and develop an internal innovative culture, adapting innovative and transformative solutions from outside of the organization to the forefront of the organization’s strategic planning efforts. The scope of internal and external innovation spans the breadth of precision medicine; new device development, product and solution development and business model development. In addition it includes remote models of care and population health management and more efficient ways to operate within an integrated health network. She has been instrumental in defining opportunities to work with innovative companies and begin to understand how home or person based technology can be integrated into a health delivery system as well as how automation can begin to transform how clinical care can be provided at the bedside. In addition, Sandra is intimately involved in the development of the new Center for Discovery and Innovation, a translational research enterprise focused on infectious disease, cancer, and regenerative medicine based on the campus of new Hackensack Meridian Health School of Medicine in Nutley. Sandra received the 2018 NJBIZ Vanguard Award, speaks at National Conferences and has published many articles in developing opportunities for growing business. Her publications have been featured in Trustee Magazine, Journal of Healthcare Financial Management, FutureAge, Hospitals and Health Networks, and the Health Strategist.
Mr. Richard Russo, MBA
President and CEO
Mr. Richard Russo is a 30+ year Medtech veteran. He is currently CEO of Endomedix Inc., a start-up working with biopolymer chemistry to develop a hemostat for use in brain surgery. Prior to Endomedix, he was the CEO of a start-up that became the largest processor in Europe of human tissue for transplantation, OST Développement in Clermont-Ferrand, France. OST serviced customers throughout Europe, Latin America and Asia. He had previously helped successfully develop and commercialize devices using pulsed electromagnetic field and ultrasound technologies to stimulate bone formation. Functionally, he has worked in sales and marketing, clinical research, regulatory affairs and strategic planning, in addition to general management. Richard earned a BA cum laude in philosophy from Boston College before pursuing graduate studies in philosophy at the Université de Fribourg in Switzerland. Richard also earned an MBA from Columbia Business School in NYC.
Dr. Anthony Scriffignano, PhD ’82 ’85
Senior Vice President and Chief Data Scientist
Dun & Bradstreet
Dr. Anthony Scriffignano is an internationally recognized data scientist with experience spanning over 35 years in multiple industries and enterprise domains. He serves on various advisory committees in government, in the private sector, and in academia. He is considered an expert on emerging trends in advanced analytics, the Big Data explosion, artificial intelligence, multilingual challenges in business identity and malfeasance in commercial and public-sector contexts. His extensive background in anomaly detection, computational linguistics and advanced inferential algorithms, has led to being primary inventor on multiple patents globally. He is a member of the OECD Network of Experts on AI working group on implementing Trustworthy AI, focused on benefiting people and planet. Dr. Scriffignano was named the U.S. Chief Data Officer of the Year in 2018 by the CDO Club; has briefed and counseled U.S. government committees and foreign governments, contributed to reports to the President on Big Data Analytics, the Strategic Vision of Emerging Technologies, and Internet and Communications Resilience; has presented as a panelist and keynote speaker at major world events including the World Internet Conference in China hosted by President Xi Jinping and the China Development Forum.
Mr. John Szabo ’88
Head of Project Management and Agile Project Manager
Mr. John Szabo describes himself as a results-oriented IT executive with extensive experience planning and leading successful projects and teams while implementing, developing and supporting customer-focused technology and support. He is a PMI Agile Certified Practitioner (PMI-ACP) with over twenty-five years of experience in industries that focus on automation, information technology, operations management, support services, and software/hardware development and deployment. He has over twenty years of project management experience in these areas, and over fifteen years of resource and budget management experience in complex technology and software. He has also managed the equipment and service deployments of voice, data, and optical networks in central office, customer premise, and laboratory environments. Mr. Szabo earned a BS in Mathematics (’88) at Montclair State University, an MBA (’94) in Information Management at Marymount University. Currently, he is a Doctor of Education candidate (expected 2024) in Leadership for Organizations at the School of Education and Health Sciences, University of Dayton.
Ms. Ni’Kita Wilson ’99
Vice President of Ideation and Innovation
Ms. Ni’Kita Wilson is an award winning cosmetic chemistry expert who holds numerous patents, has authored chapters of books, and speaks at industry conferences around the country. Ni’Kita is Vice President of Innovation and Ideation at Voyant Beauty and is Co-Founder of Love YU Collective. Ni’Kita enjoys the unique position on both the creative and consumer sides of the beauty business. On the business end, she can act as a liaison between marketing and R&D to facilitate product launches or a partner to R&D to handle creative “overload” (too many projects but not enough time or staff). For the consumer she offers insight on beauty products, answers questions about ingredients and debunks myths, new and old, that continually plague the industry. Ni’Kita is a member of the New York Chapter- Society of Cosmetic Chemists (SCC), Cosmetic Executive Women (CEW) and is on the advisory board for Health magazine and Health.com.